 | • レポートコード：QYR9ST03861 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、COPD薬の世界市場について調査・分析し、COPD薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（気管支拡張剤、PDE-4阻害剤、ステロイド、併用療法、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のCOPD薬市場動向 ・主要企業別マーケットシェア ・COPD薬の種類別市場規模2014-2019 （気管支拡張剤、PDE-4阻害剤、ステロイド、併用療法、その他） ・COPD薬の用途別市場規模2014-2019 （病院、診療所、その他） ・COPD薬の北米市場：主要企業・種類別/用途別市場規模 ・COPD薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・COPD薬の中国市場：主要企業・種類別/用途別市場規模 ・COPD薬の日本国内市場：主要企業・種類別/用途別市場規模 ・COPD薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・COPD薬のインド市場：主要企業・種類別/用途別市場規模 ・COPD薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Novartis、GlaxoSmithKline、Merck、Abbott Laboratories、Boehringer Ingelheim、AstraZeneca、Roche Holding AG、Teva Pharmaceutical Industries、Vectura Group、Mylan NV） ・COPD薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc.One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.
The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.
In 2018, the global COPD Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global COPD Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COPD Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV
Market segment by Type, the product can be split into
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global COPD Drugs status, future forecast, growth opportunity, key market and key players.
To present the COPD Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of COPD Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global COPD Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Bronchodilators
1.4.3 PDE-4 Inhibitors
1.4.4 Steroids
1.4.5 Combination Therapies
1.4.6 Others
1.5 Market by Application
1.5.1 Global COPD Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 COPD Drugs Market Size
2.2 COPD Drugs Growth Trends by Regions
2.2.1 COPD Drugs Market Size by Regions (2014-2025)
2.2.2 COPD Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 COPD Drugs Market Size by Manufacturers
3.1.1 Global COPD Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global COPD Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.2 COPD Drugs Key Players Head office and Area Served
3.3 Key Players COPD Drugs Product/Solution/Service
3.4 Date of Enter into COPD Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global COPD Drugs Market Size by Type (2014-2019)
4.2 Global COPD Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States COPD Drugs Market Size (2014-2019)
5.2 COPD Drugs Key Players in United States
5.3 United States COPD Drugs Market Size by Type
5.4 United States COPD Drugs Market Size by Application
6 Europe
6.1 Europe COPD Drugs Market Size (2014-2019)
6.2 COPD Drugs Key Players in Europe
6.3 Europe COPD Drugs Market Size by Type
6.4 Europe COPD Drugs Market Size by Application
7 China
7.1 China COPD Drugs Market Size (2014-2019)
7.2 COPD Drugs Key Players in China
7.3 China COPD Drugs Market Size by Type
7.4 China COPD Drugs Market Size by Application
8 Japan
8.1 Japan COPD Drugs Market Size (2014-2019)
8.2 COPD Drugs Key Players in Japan
8.3 Japan COPD Drugs Market Size by Type
8.4 Japan COPD Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia COPD Drugs Market Size (2014-2019)
9.2 COPD Drugs Key Players in Southeast Asia
9.3 Southeast Asia COPD Drugs Market Size by Type
9.4 Southeast Asia COPD Drugs Market Size by Application
10 India
10.1 India COPD Drugs Market Size (2014-2019)
10.2 COPD Drugs Key Players in India
10.3 India COPD Drugs Market Size by Type
10.4 India COPD Drugs Market Size by Application
11 Central & South America
11.1 Central & South America COPD Drugs Market Size (2014-2019)
11.2 COPD Drugs Key Players in Central & South America
11.3 Central & South America COPD Drugs Market Size by Type
11.4 Central & South America COPD Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 COPD Drugs Introduction
12.1.4 Pfizer Revenue in COPD Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 COPD Drugs Introduction
12.2.4 Novartis Revenue in COPD Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 COPD Drugs Introduction
12.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 COPD Drugs Introduction
12.4.4 Merck Revenue in COPD Drugs Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 COPD Drugs Introduction
12.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 COPD Drugs Introduction
12.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2014-2019)
12.6.5 Boehringer Ingelheim Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 COPD Drugs Introduction
12.7.4 AstraZeneca Revenue in COPD Drugs Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Roche Holding AG
12.8.1 Roche Holding AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 COPD Drugs Introduction
12.8.4 Roche Holding AG Revenue in COPD Drugs Business (2014-2019)
12.8.5 Roche Holding AG Recent Development
12.9 Teva Pharmaceutical Industries
12.9.1 Teva Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 COPD Drugs Introduction
12.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2014-2019)
12.9.5 Teva Pharmaceutical Industries Recent Development
12.10 Vectura Group
12.10.1 Vectura Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 COPD Drugs Introduction
12.10.4 Vectura Group Revenue in COPD Drugs Business (2014-2019)
12.10.5 Vectura Group Recent Development
12.11 Mylan NV
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table COPD Drugs Key Market Segments
Table Key Players COPD Drugs Covered
Table Global COPD Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global COPD Drugs Market Size Market Share by Type 2014-2025
Figure Bronchodilators Figures
Table Key Players of Bronchodilators
Figure PDE-4 Inhibitors Figures
Table Key Players of PDE-4 Inhibitors
Figure Steroids Figures
Table Key Players of Steroids
Figure Combination Therapies Figures
Table Key Players of Combination Therapies
Figure Others Figures
Table Key Players of Others
Table Global COPD Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure COPD Drugs Report Years Considered
Table Global COPD Drugs Market Size 2014-2025 (Million US$)
Figure Global COPD Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global COPD Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global COPD Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global COPD Drugs Market Share by Regions 2014-2019
Figure Global COPD Drugs Market Share by Regions 2014-2019
Figure Global COPD Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global COPD Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global COPD Drugs Market Share by Manufacturers (2014-2019)
Figure Global COPD Drugs Market Share by Manufacturers in 2018
Table Global COPD Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players COPD Drugs Product/Solution/Service
Table Date of Enter into COPD Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table Global COPD Drugs Market Size Share by Type (2014-2019)
Figure Global COPD Drugs Market Size Market Share by Type (2014-2019)
Table Global COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table Global COPD Drugs Market Size Share by Application (2014-2019)
Figure Global COPD Drugs Market Size Market Share by Application (2014-2019)
Figure Global COPD Drugs Revenue Market Share by Application in 2018
Figure United States COPD Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players COPD Drugs Market Share (2018-2019)
Table United States COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table United States COPD Drugs Market Share by Type (2014-2019)
Table United States COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table United States COPD Drugs Market Share by Application (2014-2019)
Figure Europe COPD Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players COPD Drugs Market Share (2018-2019)
Table Europe COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe COPD Drugs Market Share by Type (2014-2019)
Table Europe COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe COPD Drugs Market Share by Application (2014-2019)
Figure China COPD Drugs Market Size 2014-2019 (Million US$)
Table China Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table China Key Players COPD Drugs Market Share (2018-2019)
Table China COPD Drugs Market Size by Type (2014-20189) (Million US$)
Table China COPD Drugs Market Share by Type (2014-2019)
Table China COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table China COPD Drugs Market Share by Application (2014-2019)
Figure Japan COPD Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players COPD Drugs Market Share (2018-2019)
Table Japan COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan COPD Drugs Market Share by Type (2014-2019)
Table Japan COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan COPD Drugs Market Share by Application (2014-2019)
Figure Southeast Asia COPD Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players COPD Drugs Market Share (2018-2019)
Table Southeast Asia COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia COPD Drugs Market Share by Type (2014-2019)
Table Southeast Asia COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia COPD Drugs Market Share by Application (2014-2019)
Figure India COPD Drugs Market Size 2014-2019 (Million US$)
Table India Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table India Key Players COPD Drugs Market Share (2018-2019)
Table India COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table India COPD Drugs Market Share by Type (2014-2019)
Table India COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table India COPD Drugs Market Share by Application (2014-2019)
Figure Central & South America COPD Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players COPD Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players COPD Drugs Market Share (2018-2019)
Table Central & South America COPD Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America COPD Drugs Market Share by Type (2014-2019)
Table Central & South America COPD Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America COPD Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in COPD Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Merck Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Roche Holding AG Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Vectura Group Company Details
Table Vectura Group Revenue in COPD Drugs Business (2014-2019)(Million US$)
Figure Vectura Group Revenue Growth Rate in COPD Drugs Business (2014-2019)
Table Vectura Group Recent Development
Table Mylan NV Company Details
Table Global COPD Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global COPD Drugs Market Size Share by Regions (2019-2025)
Figure Global COPD Drugs Market Size Share by Regions in 2025
Figure United States COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America COPD Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global COPD Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global COPD Drugs Market Size by Product (2019-2025)
Figure Global COPD Drugs Market Size by Product in 2025
Table Global COPD Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global COPD Drugs Market Size by Application (2019-2025)
Figure Global COPD Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
喘息及びCOPD薬の世界市場：インサイト・予測 Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.The Globa…- 喘息及びCOPD薬の世界市場：インサイト・予測 Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Conse…
- 世界のCOPD用粘液クリアランスデバイス市場：専門的調査 Mucus clearance devices are used to help remove mucus from the airways. The global Mucus Clearance Devices for COPD market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Mucus Clearance Devices …
- 世界のCOPD・喘息治療薬市場：動向・競争分析 The COPD and Asthma Drug Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for…
- 世界のCOPD遠隔監視システム市場：動向・競争分析 COPD telehealth involves remote daily collection of vital signs and respiratory symptoms from patients using electronic means. A typical COPD telehealth kit consists of “peripheral devices” to collect the vital signs, such as blood oxygen saturation, connected to an electronic platform, for example …